Rebamipide protects against activation of neutrophils by Helicobacter pylori

Our objectives were to determine whether rebamipide, a unique antiulcer agent, would inhibit adhesive reactions between neutrophils and endothelial cells as well as the production of active oxygen species from neutrophils elicited by an extract of H. pylori. A water extract of H. pylori that was pre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Digestive diseases and sciences 1996-06, Vol.41 (6), p.1139-1144
Hauptverfasser: YOSHIDA, N, YOSHIKAWA, T, MUKAI, F, KONDO, M, IINUMA, S, ARAI, M, TAKENAKA, S, SAKAMOTO, K, MIYAJIMA, T, NAKAMURA, Y, YAGI, N, NAITO, Y
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1144
container_issue 6
container_start_page 1139
container_title Digestive diseases and sciences
container_volume 41
creator YOSHIDA, N
YOSHIKAWA, T
MUKAI, F
KONDO, M
IINUMA, S
ARAI, M
TAKENAKA, S
SAKAMOTO, K
MIYAJIMA, T
NAKAMURA, Y
YAGI, N
NAITO, Y
description Our objectives were to determine whether rebamipide, a unique antiulcer agent, would inhibit adhesive reactions between neutrophils and endothelial cells as well as the production of active oxygen species from neutrophils elicited by an extract of H. pylori. A water extract of H. pylori that was prepared from biopsy materials obtained from a patient with gastric ulcer increased the surface expression of CD18 on human neutrophils isolated from peripheral blood, the adhesion of neutrophil-endothelial cells, and the production of active oxygen species by neutrophils. Rebamipide, at concentrations of 10(-5) and 10(-6) M, reduced the adherence of neutrophils to endothelial cells as well as the CD18 expression on neutrophils induced by this bacterial extract. Rebamipide also inhibited the production of active oxygen species from neutrophils stimulated by H. pylori extract. These results suggest that rebamipide protects against the gastric mucosal inflammation associated with H. pylori by inhibiting neutrophil function.
doi_str_mv 10.1007/BF02088229
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_78102808</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78102808</sourcerecordid><originalsourceid>FETCH-LOGICAL-p235t-2f499f17e0375544f5d439d53c2f6b24c37adf7efdd524348708d821f408f5943</originalsourceid><addsrcrecordid>eNo9j8tLxDAYxIMo67p68S7kIN6qX15NetTFdYWCIHouaR4a6csmFfa_t2DxNAPzY5hB6JLALQGQdw87oKAUpcURWhMhWUZFro7RGkg-e0LyU3QW4xcAFJLkK7RSueCE8zUqX12t2zAE6_Aw9smZFLH-0KGLCWuTwo9Ooe9w73HnpjT2w2doIq4PeO-aYPp6ZtyIh0PTj-EcnXjdRHex6Aa97x7ftvusfHl63t6X2UCZSBn1vCg8kQ6YFIJzLyxnhRXMUJ_XlBsmtfXSeWsF5YwrCcoqSjwH5UXB2Qbd_PXOi78nF1PVhmhc0-jO9VOspCJAFagZvFrAqW6drYYxtHo8VMv9Ob9ech2NbvyoOxPiP8YIAyEK9gu0FGfk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78102808</pqid></control><display><type>article</type><title>Rebamipide protects against activation of neutrophils by Helicobacter pylori</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>YOSHIDA, N ; YOSHIKAWA, T ; MUKAI, F ; KONDO, M ; IINUMA, S ; ARAI, M ; TAKENAKA, S ; SAKAMOTO, K ; MIYAJIMA, T ; NAKAMURA, Y ; YAGI, N ; NAITO, Y</creator><creatorcontrib>YOSHIDA, N ; YOSHIKAWA, T ; MUKAI, F ; KONDO, M ; IINUMA, S ; ARAI, M ; TAKENAKA, S ; SAKAMOTO, K ; MIYAJIMA, T ; NAKAMURA, Y ; YAGI, N ; NAITO, Y</creatorcontrib><description>Our objectives were to determine whether rebamipide, a unique antiulcer agent, would inhibit adhesive reactions between neutrophils and endothelial cells as well as the production of active oxygen species from neutrophils elicited by an extract of H. pylori. A water extract of H. pylori that was prepared from biopsy materials obtained from a patient with gastric ulcer increased the surface expression of CD18 on human neutrophils isolated from peripheral blood, the adhesion of neutrophil-endothelial cells, and the production of active oxygen species by neutrophils. Rebamipide, at concentrations of 10(-5) and 10(-6) M, reduced the adherence of neutrophils to endothelial cells as well as the CD18 expression on neutrophils induced by this bacterial extract. Rebamipide also inhibited the production of active oxygen species from neutrophils stimulated by H. pylori extract. These results suggest that rebamipide protects against the gastric mucosal inflammation associated with H. pylori by inhibiting neutrophil function.</description><identifier>ISSN: 0163-2116</identifier><identifier>EISSN: 1573-2568</identifier><identifier>DOI: 10.1007/BF02088229</identifier><identifier>PMID: 8654144</identifier><identifier>CODEN: DDSCDJ</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Alanine - analogs &amp; derivatives ; Alanine - pharmacology ; Anti-Ulcer Agents - pharmacology ; Biological and medical sciences ; CD18 Antigens - analysis ; Cell Adhesion ; Digestive system ; Electron Spin Resonance Spectroscopy ; Endothelium, Vascular - physiology ; Flow Cytometry ; Helicobacter pylori - physiology ; Humans ; In Vitro Techniques ; Medical sciences ; Neutrophil Activation - drug effects ; Neutrophils - immunology ; Neutrophils - metabolism ; Pharmacology. Drug treatments ; Quinolones - pharmacology ; Reactive Oxygen Species - metabolism</subject><ispartof>Digestive diseases and sciences, 1996-06, Vol.41 (6), p.1139-1144</ispartof><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3130559$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8654144$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>YOSHIDA, N</creatorcontrib><creatorcontrib>YOSHIKAWA, T</creatorcontrib><creatorcontrib>MUKAI, F</creatorcontrib><creatorcontrib>KONDO, M</creatorcontrib><creatorcontrib>IINUMA, S</creatorcontrib><creatorcontrib>ARAI, M</creatorcontrib><creatorcontrib>TAKENAKA, S</creatorcontrib><creatorcontrib>SAKAMOTO, K</creatorcontrib><creatorcontrib>MIYAJIMA, T</creatorcontrib><creatorcontrib>NAKAMURA, Y</creatorcontrib><creatorcontrib>YAGI, N</creatorcontrib><creatorcontrib>NAITO, Y</creatorcontrib><title>Rebamipide protects against activation of neutrophils by Helicobacter pylori</title><title>Digestive diseases and sciences</title><addtitle>Dig Dis Sci</addtitle><description>Our objectives were to determine whether rebamipide, a unique antiulcer agent, would inhibit adhesive reactions between neutrophils and endothelial cells as well as the production of active oxygen species from neutrophils elicited by an extract of H. pylori. A water extract of H. pylori that was prepared from biopsy materials obtained from a patient with gastric ulcer increased the surface expression of CD18 on human neutrophils isolated from peripheral blood, the adhesion of neutrophil-endothelial cells, and the production of active oxygen species by neutrophils. Rebamipide, at concentrations of 10(-5) and 10(-6) M, reduced the adherence of neutrophils to endothelial cells as well as the CD18 expression on neutrophils induced by this bacterial extract. Rebamipide also inhibited the production of active oxygen species from neutrophils stimulated by H. pylori extract. These results suggest that rebamipide protects against the gastric mucosal inflammation associated with H. pylori by inhibiting neutrophil function.</description><subject>Alanine - analogs &amp; derivatives</subject><subject>Alanine - pharmacology</subject><subject>Anti-Ulcer Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>CD18 Antigens - analysis</subject><subject>Cell Adhesion</subject><subject>Digestive system</subject><subject>Electron Spin Resonance Spectroscopy</subject><subject>Endothelium, Vascular - physiology</subject><subject>Flow Cytometry</subject><subject>Helicobacter pylori - physiology</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Medical sciences</subject><subject>Neutrophil Activation - drug effects</subject><subject>Neutrophils - immunology</subject><subject>Neutrophils - metabolism</subject><subject>Pharmacology. Drug treatments</subject><subject>Quinolones - pharmacology</subject><subject>Reactive Oxygen Species - metabolism</subject><issn>0163-2116</issn><issn>1573-2568</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9j8tLxDAYxIMo67p68S7kIN6qX15NetTFdYWCIHouaR4a6csmFfa_t2DxNAPzY5hB6JLALQGQdw87oKAUpcURWhMhWUZFro7RGkg-e0LyU3QW4xcAFJLkK7RSueCE8zUqX12t2zAE6_Aw9smZFLH-0KGLCWuTwo9Ooe9w73HnpjT2w2doIq4PeO-aYPp6ZtyIh0PTj-EcnXjdRHex6Aa97x7ftvusfHl63t6X2UCZSBn1vCg8kQ6YFIJzLyxnhRXMUJ_XlBsmtfXSeWsF5YwrCcoqSjwH5UXB2Qbd_PXOi78nF1PVhmhc0-jO9VOspCJAFagZvFrAqW6drYYxtHo8VMv9Ob9ech2NbvyoOxPiP8YIAyEK9gu0FGfk</recordid><startdate>19960601</startdate><enddate>19960601</enddate><creator>YOSHIDA, N</creator><creator>YOSHIKAWA, T</creator><creator>MUKAI, F</creator><creator>KONDO, M</creator><creator>IINUMA, S</creator><creator>ARAI, M</creator><creator>TAKENAKA, S</creator><creator>SAKAMOTO, K</creator><creator>MIYAJIMA, T</creator><creator>NAKAMURA, Y</creator><creator>YAGI, N</creator><creator>NAITO, Y</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19960601</creationdate><title>Rebamipide protects against activation of neutrophils by Helicobacter pylori</title><author>YOSHIDA, N ; YOSHIKAWA, T ; MUKAI, F ; KONDO, M ; IINUMA, S ; ARAI, M ; TAKENAKA, S ; SAKAMOTO, K ; MIYAJIMA, T ; NAKAMURA, Y ; YAGI, N ; NAITO, Y</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p235t-2f499f17e0375544f5d439d53c2f6b24c37adf7efdd524348708d821f408f5943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Alanine - analogs &amp; derivatives</topic><topic>Alanine - pharmacology</topic><topic>Anti-Ulcer Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>CD18 Antigens - analysis</topic><topic>Cell Adhesion</topic><topic>Digestive system</topic><topic>Electron Spin Resonance Spectroscopy</topic><topic>Endothelium, Vascular - physiology</topic><topic>Flow Cytometry</topic><topic>Helicobacter pylori - physiology</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Medical sciences</topic><topic>Neutrophil Activation - drug effects</topic><topic>Neutrophils - immunology</topic><topic>Neutrophils - metabolism</topic><topic>Pharmacology. Drug treatments</topic><topic>Quinolones - pharmacology</topic><topic>Reactive Oxygen Species - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>YOSHIDA, N</creatorcontrib><creatorcontrib>YOSHIKAWA, T</creatorcontrib><creatorcontrib>MUKAI, F</creatorcontrib><creatorcontrib>KONDO, M</creatorcontrib><creatorcontrib>IINUMA, S</creatorcontrib><creatorcontrib>ARAI, M</creatorcontrib><creatorcontrib>TAKENAKA, S</creatorcontrib><creatorcontrib>SAKAMOTO, K</creatorcontrib><creatorcontrib>MIYAJIMA, T</creatorcontrib><creatorcontrib>NAKAMURA, Y</creatorcontrib><creatorcontrib>YAGI, N</creatorcontrib><creatorcontrib>NAITO, Y</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Digestive diseases and sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>YOSHIDA, N</au><au>YOSHIKAWA, T</au><au>MUKAI, F</au><au>KONDO, M</au><au>IINUMA, S</au><au>ARAI, M</au><au>TAKENAKA, S</au><au>SAKAMOTO, K</au><au>MIYAJIMA, T</au><au>NAKAMURA, Y</au><au>YAGI, N</au><au>NAITO, Y</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rebamipide protects against activation of neutrophils by Helicobacter pylori</atitle><jtitle>Digestive diseases and sciences</jtitle><addtitle>Dig Dis Sci</addtitle><date>1996-06-01</date><risdate>1996</risdate><volume>41</volume><issue>6</issue><spage>1139</spage><epage>1144</epage><pages>1139-1144</pages><issn>0163-2116</issn><eissn>1573-2568</eissn><coden>DDSCDJ</coden><abstract>Our objectives were to determine whether rebamipide, a unique antiulcer agent, would inhibit adhesive reactions between neutrophils and endothelial cells as well as the production of active oxygen species from neutrophils elicited by an extract of H. pylori. A water extract of H. pylori that was prepared from biopsy materials obtained from a patient with gastric ulcer increased the surface expression of CD18 on human neutrophils isolated from peripheral blood, the adhesion of neutrophil-endothelial cells, and the production of active oxygen species by neutrophils. Rebamipide, at concentrations of 10(-5) and 10(-6) M, reduced the adherence of neutrophils to endothelial cells as well as the CD18 expression on neutrophils induced by this bacterial extract. Rebamipide also inhibited the production of active oxygen species from neutrophils stimulated by H. pylori extract. These results suggest that rebamipide protects against the gastric mucosal inflammation associated with H. pylori by inhibiting neutrophil function.</abstract><cop>Heidelberg</cop><pub>Springer</pub><pmid>8654144</pmid><doi>10.1007/BF02088229</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0163-2116
ispartof Digestive diseases and sciences, 1996-06, Vol.41 (6), p.1139-1144
issn 0163-2116
1573-2568
language eng
recordid cdi_proquest_miscellaneous_78102808
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Alanine - analogs & derivatives
Alanine - pharmacology
Anti-Ulcer Agents - pharmacology
Biological and medical sciences
CD18 Antigens - analysis
Cell Adhesion
Digestive system
Electron Spin Resonance Spectroscopy
Endothelium, Vascular - physiology
Flow Cytometry
Helicobacter pylori - physiology
Humans
In Vitro Techniques
Medical sciences
Neutrophil Activation - drug effects
Neutrophils - immunology
Neutrophils - metabolism
Pharmacology. Drug treatments
Quinolones - pharmacology
Reactive Oxygen Species - metabolism
title Rebamipide protects against activation of neutrophils by Helicobacter pylori
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T06%3A09%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rebamipide%20protects%20against%20activation%20of%20neutrophils%20by%20Helicobacter%20pylori&rft.jtitle=Digestive%20diseases%20and%20sciences&rft.au=YOSHIDA,%20N&rft.date=1996-06-01&rft.volume=41&rft.issue=6&rft.spage=1139&rft.epage=1144&rft.pages=1139-1144&rft.issn=0163-2116&rft.eissn=1573-2568&rft.coden=DDSCDJ&rft_id=info:doi/10.1007/BF02088229&rft_dat=%3Cproquest_pubme%3E78102808%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78102808&rft_id=info:pmid/8654144&rfr_iscdi=true